🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to evaluate the progress free surviv...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-04-23
Trial ID
NCT04282980
Treatments Being Tested
The purpose of this clinical trial is to learn about the safety and effects...
Status
Active Not Recruiting
Location
Stanford Women's Cancer Center
Start Date
2023-03-01
Trial ID
NCT05573555
Treatments Being Tested
Use lay language. Oxaliplatin is a reference anticancer drug in the treatme...
Status
Completed
Location
CHU de Clermont-Ferrand
Start Date
2013-02-02
Trial ID
NCT01775449
Treatments Being Tested
The study is to evaluate the R0 resection rate of patients with unresectabl...
Status
Terminated
Location
Zhejiang procincial people's hospital
Start Date
2017-11-20
Trial ID
NCT03585062
Treatments Being Tested
The pharmacist, as a specialist of medications, occupies a strategic positi...
Status
Completed
Location
CHU de Clermont-Ferrand
Start Date
2017-06-20
Trial ID
NCT03275675
Treatments Being Tested
The objective of this study is to improve medication, symptom, and disease ...
Status
Terminated
Location
University of Michigan Rogel Cancer Center
Start Date
2021-03-26
Trial ID
NCT04595851
This study is being done to determine if sending reminder text messages hel...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-06-28
Trial ID
NCT02833246
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Usc Norris Comprehensive Cancer Center (Nccc)
Start Date
2024-12-09
Trial ID
NCT06625593
Treatments Being Tested
The COVID-19 pandemic has profoundly changed the organisation of care. Tele...
Status
Completed
Location
Service Pharmaceutique, Hospices Civils de Lyon
Start Date
2021-10-05
Trial ID
NCT05069662
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested